About us

BlueGnome was founded in Cambridge, UK, in 2002 by a team of scientists who developed a novel mathematical technology for the analysis of genetic data following the sequencing of the human genome in 2000.

With the support of the University of Cambridge and the Wellcome Trust BlueGnome went on to assemble a world class team of mathematicians, biologists and software engineers with the aim of developing a range of molecular tests which used these advances to improve human health.

In February 2006 BlueGnome released the CytoChip, a powerful new approach for the investigation of genetic abnormalities. The CytoChip is now used in over 25 countries world wide. Since 2006 over 50,000 samples have been investigated using the CytoChip, mainly associated with developmental delay or with complex leukaemia's.

In 2008 BlueGnome applied its unique combination of technology and expertise to the problem of counting the chromosomes in a single human cell.  In collaboration with some of the world’s leading IVF centres  BlueGnome developed 24sure and as part of a consented study in September 2009 the first 24sure baby, Oliver, was born in the UK.

BlueGnome is privately held, profitable and ranked in the top 25 fastest growing businesses in the UK with over 85% of sales going for export to major laboratories around the world.